Home Drug Injury Rezulin Liver Damage Settlement

Rezulin Liver Damage Settlement

Rezulin (troglitazone) was a “new” type of antidiabetic medication introduced in 1997 to treat Type 2 diabetes. Originally rejected due to concerns about liver damage, the drug was approved for the market in March 1997, only to be withdrawn in March 2000 due to at least 430 cases of liver failure being reported in patients. Seeger Weiss was a court-appointed member of the Plaintiffs’ Executive Committee, and the firm played a pivotal role in securing an estimated $750 million on behalf of patients who were harmed after taking Rezulin.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Jul 28, 2025
Rezulin Liver Damage Lawsuit Settlement

What’s on this page:

Firm News

December 19, 2025
Parvin Aminolroaya appointed as Member of the American Law Institute

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been elected as a member of the American Law Institute (ALI), one of the nation’s most prestigious legal organizations. Election to ALI is a highly selective honor that recognizes lawyers and judges who have demonstrated exceptional professional achievement and a commitment to improving the […]

Read More
November 19, 2025
Shauna Itri Appointed to Sedona Conference Working Group 1 (WG1) Steering Committee

Seeger Weiss is proud to announce that Partner Shauna Itri has been appointed to the Sedona Conference Working Group 1 (WG1) Steering Committee for a three-year term beginning January 1, 2026. This appointment reflects Shauna’s longstanding leadership and dedication to advancing best practices in eDiscovery and information governance. Shauna has played a pivotal role in […]

Read More
November 7, 2025
Seeger Weiss Recognized Nationally and Regionally in the 16th Edition of Best Law Firms® in the United States

Seeger Weiss received national and regional rankings in the 16th edition of Best Law Firms® in the United States. The recognition highlights the firm’s work in mass tort, product liability, personal injury, medical malpractice, and commercial litigation, personal injury, medical malpractice, and commercial litigation. The Best Law Firms® rankings are a trusted standard in the […]

Read More
November 4, 2025
Founding Partner Christopher Seeger Wins Lifetime Achievement Award and Firm Wins Class Action Litigation Department of the Year

Seeger Weiss is proud to announce two honors at the 2025 New Jersey Legal Awards hosted by the New Jersey Law Journal. Founding partner Christopher Seeger received the Lifetime Achievement Award, and the firm won Litigation Department of the Year Award in the Class Action category. Partner Jennifer Scullion was selected as a finalist for […]

Read More